Intelligent Bio Solutions Inc. (NASDAQ:INBS) does about 54.42K shares in volume on a normal day but saw 146275899 shares change hands in Monday trading. The company now has a market cap of 18.09M USD. Its current market price is $1.03, marking an increase of 293.13% compared to the previous close of $0.26. The 52 week high reached by this stock is $1.54 whilst the lowest price level in 52 weeks is $0.17. The script in recent trading has seen the stock touch a high of $1.60 and a low of $0.92.
Intelligent Bio Solutions Inc. (INBS) has a 20-day trading average at $0.2841 and the current price is -33.12% off the 52-week high compared with 505.88% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.3325 and its 200-day simple moving average is $0.5507. If we look at the stock’s price movements over the week, volatility stands at 24.29%, which decreases to 19.18% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 89.55 to suggest the stock is overbought.
1 analysts observing the Intelligent Bio Solutions Inc. (INBS) stock have set the 12-month price targets for the company’s shares at between $1.60 and $1.60. The consensus objective for the share price is $1.60, suggesting that the stock has a potential upside of 35.62% over the period. The median price target is 35.62% away from the current levels at $1.60.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The current price level is 317.10%, 221.54%, and 86.73% away from its SMA20, SMA50, and SMA200 respectively, with the INBS price moving below the 50-day SMA on January 23. Intelligent Bio Solutions Inc. (INBS) stock is up 268.25% over the week and 261.66% over the past month. Its price is 415.26% year-to-date and -33.55% over the past year.
The stock last released its quarterly earnings report for quarter ended 6/29/2022, with the company’s earnings per share (EPS) of -$0.14 above consensus estimates by $0.04. The company’s next earnings report is expected on 05/09/2023, with forecasts estimating quarterly EPS at $0 and -$0.31 for whole year. INBS’s earnings per share are forecast to grow by 45.60% this year and 71.00% over next year.
Its 12-month price target is $1.60. To reach the target analysts have set, the stock logically needs to grow 35.62 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $1.60, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $1.60.
Outstanding shares total 14.89M with insiders holding 9.05% of the shares and institutional holders owning 2.79% of the company’s common stock. The company has a return on investment of -126.30% and return on equity of -105.00%. Price to book ratio is 2.94 and price to sales ratio is 25.84.
Fidelity Extended Market Index Fu isn’t the only investment manager who changed stakes and is followed by Vanguard Extended Market Index Fu, which added 462.0 shares to end up with 11,850 shares worth $2370.0.